As a lot as $3 billion in debt will come due for main U.S. cannabis operators by the tip of 2026, a “wave” of maturities that could portend a big shake-up within the regulated trade.
Analysts generally agree that companies have ample time to find favorable terms for refinancing their debt.
However, factors beyond the industry’s control – such as significant federal or state reforms that could open new markets and streamline operations for existing businesses, or the complete absence of such reforms – will also determine whether companies are forced to sell assets, shut down, or surrender more control to their lenders, experts told MEDCAN24.
Jesse Redmond of Water Tower Analysis in California, an investment advisory firm, said that the image painted by cannabis was “unpleasant”.
He added, “I think anyone investing in cannabis should be involved.”